The impact of the new WHO antiretroviral treatment guidelines on HIV epidemic dynamics and cost in South Africa.
about
Review: [corrected] The changing face of the HIV epidemic in sub-Saharan AfricaElimination of HIV in South Africa through expanded access to antiretroviral therapy: a model comparison studyThe Impact of Company-Level ART Provision to a Mining Workforce in South Africa: A Cost-Benefit AnalysisExpanding ART for treatment and prevention of HIV in South Africa: estimated cost and cost-effectiveness 2011-2050Universal test, treat, and keep: improving ART retention is key in cost-effective HIV control in Uganda.Health benefits, costs, and cost-effectiveness of earlier eligibility for adult antiretroviral therapy and expanded treatment coverage: a combined analysis of 12 mathematical models.HIV treatment as prevention: systematic comparison of mathematical models of the potential impact of antiretroviral therapy on HIV incidence in South AfricaHIV treatment as prevention: modelling the cost of antiretroviral treatment--state of the art and future directions.HIV treatment as prevention: issues in economic evaluation.Attrition through multiple stages of pre-treatment and ART HIV care in South AfricaHigh burden of STIs among HIV-infected adults prior to initiation of ART in South Africa: a retrospective cohort study.Understanding the potential impact of a combination HIV prevention intervention in a hyper-endemic community.High coverage of ART associated with decline in risk of HIV acquisition in rural KwaZulu-Natal, South AfricaDramatic increase in HIV prevalence after scale-up of antiretroviral treatment.Equity in utilization of antiretroviral therapy for HIV-infected people in South Africa: a systematic review.Human resources needs for universal access to antiretroviral therapy in South Africa: a time and motion study.Integrated strategies for combination HIV prevention: principles and examples for men who have sex with men in the Americas and heterosexual African populations.Oral antiretroviral drugs as public health tools for HIV prevention: global implications for adherence, drug resistance, and the success of HIV treatment programs.Home testing and counselling to reduce HIV incidence in a generalised epidemic setting: a mathematical modelling analysis.Evolving uses of oral reverse transcriptase inhibitors in the HIV-1 epidemic: from treatment to preventionDisengagement from care in a decentralised primary health care antiretroviral treatment programme: cohort study in rural South Africa.Age-dependent partnering and the HIV transmission chain: a microsimulation analysis.Changing HIV treatment eligibility under health system constraints in sub-Saharan Africa: investment needs, population health gains, and cost-effectiveness.Balancing efficiency, equity and feasibility of HIV treatment in South Africa - development of programmatic guidance.The impact of antiretroviral treatment on the age composition of the HIV epidemic in sub-Saharan Africa.Obligation to family during times of transition: care, support and the response to HIV and AIDS in rural South Africa.Impact of Extended Combination Antiretroviral Therapy on the Decline of HIV Prevalence in Pregnant Women in Malawi.Massive benefits of antiretroviral therapy in Africa.A state transition framework for patient-level modeling of engagement and retention in HIV care using longitudinal cohort data.Choice of time horizon critical in estimating costs and effects of changes to HIV programmes.Evaluation of the impact of immediate versus WHO recommendations-guided antiretroviral therapy initiation on HIV incidence: the ANRS 12249 TasP (Treatment as Prevention) trial in Hlabisa sub-district, KwaZulu-Natal, South Africa: study protocol for aThe South African disability grant: Influence on HIV treatment outcomes and household well-being in KwaZulu-Natal
P2860
Q27022927-A455A766-E5DA-41A2-B358-E8C7492391ECQ28534568-5CCEE834-06CA-41DF-AF69-6DD74573638DQ28608172-23D38C13-EF62-4E83-9DE0-F8E328591271Q28732123-06B9F7F2-E47D-47D4-8AF9-D58CF2FFD611Q33634785-74257C98-B65D-4E33-8A7E-C93FBBE67370Q33966505-7104CF84-5CAE-4056-A5FF-EEE145B1406FQ34339465-6DA384FF-A5A5-4E8F-9C6C-56DAD4A2FC64Q34339471-54D91211-8FE6-4BFB-B0DC-714794ACC49FQ34339555-2FF6AF78-CFA1-4A49-9949-8E298231615CQ34374074-1CE18651-4F78-4DBB-8572-F1C25803E6E6Q34518380-43124629-5D3A-45C3-AA19-318681657956Q34571215-DB804715-6B80-423B-99AC-5702216C04D5Q34629087-32BC7243-67D5-438A-AB17-3C047822825BQ34687399-5BE85786-C1C0-476E-BBD9-2BE3D0DCBCB8Q35663235-471D6505-761A-440E-81E6-818CE8278831Q36487079-33AFD007-2615-4AA5-A48F-63252818AA3DQ37003069-165E7ACF-D86B-481D-89B4-CD5209F727D3Q37003938-C4289167-8E95-4256-8501-9EBA557B6772Q37052795-C7F06D1A-8D42-44D6-ADA7-AC0D49352E95Q37071435-C953DC91-5B1A-41C0-A95D-377C1AA0B762Q37177440-9122E32A-27C6-47E4-8D5E-8AEADBD0CC83Q37204215-BD3EFCF9-1B58-483B-B583-5DA3203AEDC3Q37244536-FBD1E059-3B7A-4031-8AA3-67DF728A7BD2Q37365039-3C1FA904-D6CF-411A-B3EE-5F20B56620B1Q37455928-FF0D9A84-B501-4665-839B-ABD009F55399Q39141743-F58819AF-69F2-4D30-A8F9-EF5D8B2AA90FQ39182497-BF3C866C-A88A-498D-82E0-5A9B427ABAE9Q42733583-50858487-D55B-494A-9E87-FE0527C0ACE5Q46329396-BB2603D8-9468-41B6-BD81-7AD267756A91Q55088517-36A5BE2B-E325-48E2-9E57-A293EDBEE66EQ55546871-9CB78BE8-F607-497C-8B14-6014867B85C5Q58276149-BAC9493C-CBE5-4DA6-AF03-07610BEF7546
P2860
The impact of the new WHO antiretroviral treatment guidelines on HIV epidemic dynamics and cost in South Africa.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
The impact of the new WHO anti ...... mics and cost in South Africa.
@ast
The impact of the new WHO anti ...... mics and cost in South Africa.
@en
type
label
The impact of the new WHO anti ...... mics and cost in South Africa.
@ast
The impact of the new WHO anti ...... mics and cost in South Africa.
@en
prefLabel
The impact of the new WHO anti ...... mics and cost in South Africa.
@ast
The impact of the new WHO anti ...... mics and cost in South Africa.
@en
P2093
P2860
P50
P921
P1433
P1476
The impact of the new WHO anti ...... mics and cost in South Africa.
@en
P2093
Jan A C Hontelez
Rob Baltussen
Roel Bakker
P2860
P304
P356
10.1371/JOURNAL.PONE.0021919
P407
P577
2011-07-20T00:00:00Z